The consumer-genomics company 23andMe just sold its biobank of customer genetic data to drugmaker Regeneron for $256 million.

cross-posted from: https://lemm.ee/post/64477597

Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.

  • Tabitha ☢️[she/her]English
    56•26 days ago

    People who made deletion requests about to find out some new terms like soft deletes, automated data reselling, and perpetual circulation.